Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 1Prostatic Neoplasms 1Pain 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Bone Neoplasms 1Agnosia 1

Interventions

pembrolizumab 157Gemcitabine 140Capecitabine 123Paclitaxel 121Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Docetaxel 98Leucovorin 97Cisplatin 90Radiosurgery 88Irinotecan 88Carboplatin 86Cyclophosphamide 72Cetuximab 72Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Samarium × Clear all
NCT00374751 2019-08-26

Effect of Samarium on the Relief of Pain Due to Vertebral Metastases

New York Presbyterian Brooklyn Methodist Hospital

Phase 1/2 Completed
29 enrolled

Agnosia, Neoplasm Metastasis, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡